Hicks RJ - Search Results

1

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.

Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny C, Hofman MS, Eiber M, Schwarzenbock S, Castellucci P, Bellisario C, Chauvie S, Bergesio F, Emmett L, Haberkorn U, Virgolini I, Schwaiger M, Hicks RJ, Krause BJ, Chiti A. Fanti S, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1622-1635. doi: 10.1007/s00259-017-3725-1. Epub 2017 May 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28536833

2

Iodine-123 N-methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors.

Hicks RJ, Kassiou M, Eu P, Katsifis AG, Garra M, Power J, Najdovski L, Lambrecht RM. Hicks RJ, et al. Eur J Nucl Med. 1995 Apr;22(4):339-45. doi: 10.1007/BF00941851. Eur J Nucl Med. 1995. PMID: 7607265

3

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.

Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1596-604. J Nucl Med. 2001. PMID: 11696627 Free article. Clinical Trial.

4

The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.

Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1605-13. J Nucl Med. 2001. PMID: 11696628 Free article. Clinical Trial.

5

Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.

Kalff V, Hicks RJ, Ware RE, Greer B, Binns DS, Hogg A. Kalff V, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):506-15. doi: 10.1007/s00259-001-0735-8. Epub 2002 Feb 15. Eur J Nucl Med Mol Imaging. 2002. PMID: 11914889

6

The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.

Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. Kalff V, et al. Among authors: hicks rj. J Nucl Med. 2002 Apr;43(4):492-9. J Nucl Med. 2002. PMID: 11937593 Free article.

7

The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin.

Scott CL, Kudaba I, Stewart JM, Hicks RJ, Rischin D. Scott CL, et al. Among authors: hicks rj. Mol Imaging Biol. 2005 May-Jun;7(3):236-43. doi: 10.1007/s11307-005-4114-x. Mol Imaging Biol. 2005. PMID: 15912428

8

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.

Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, Peters LJ. Hicks RJ, et al. Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1384-91. doi: 10.1007/s00259-005-1880-2. Epub 2005 Aug 26. Eur J Nucl Med Mol Imaging. 2005. PMID: 16133382 Clinical Trial.

9

The role of PET in monitoring therapy.

Hicks RJ. Hicks RJ. Cancer Imaging. 2005 Jun 21;5(1):51-7. doi: 10.1102/1470-7330.2005.0006. Cancer Imaging. 2005. PMID: 16154820 Free PMC article.

10

Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.

Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ. Kalff V, et al. Among authors: hicks rj. J Nucl Med. 2006 Jan;47(1):14-22. J Nucl Med. 2006. PMID: 16391182 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page